Search clinical trials for: Paliperidone extended-release
Total 228 results
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Friends Research Institute, Inc.Not yet recruiting
-
National Institute on Drug Abuse (NIDA)Not yet recruitingMethamphetamine-dependence | Methamphetamine Abuse
-
Consorcio Centro de Investigación Biomédica en...Instituto de Salud Carlos IIINot yet recruitingDiabetes | Schizophrenia | Lipid Metabolism Disorders | NAFLD | Psychosis | Treatment-resistant Schizophrenia | Side Effect
-
Rhode Island HospitalRecruitingOpioid Use Disorder | Human Immunodeficiency VirusUnited States
-
University of LiverpoolObafemi Awolowo University Teaching Hospital; Federal Medical Centre, Makurdi; Federal Neuropsychiatric Hospital, Yaba and other collaboratorsRecruitingSchizophrenia | Pregnancy | Mania | Psychosis | Breastfeeding | Antipsychotic Agents | Drug Exposure in Utero | Drug Exposure Via Breast MilkNigeria
-
Ohio State UniversityRecruitingTreatment-resistant SchizophreniaUnited States
-
University of MichiganNational Institute on Aging (NIA)RecruitingPostoperative Delirium | Postoperative Cognitive Dysfunction | Mild Cognitive ImpairmentUnited States
-
Centre for Addiction and Mental HealthJanssen Inc.RecruitingSchizophrenia | Schizophrenia RelapseCanada
-
Deborah DoroshowRecruitingPTEN-null Advanced Solid TumorsUnited States
-
Xiaoxiang ChenRecruitingOvarian Cancer | PARP Inhibitor | Clinical MarkerChina
-
NYU Langone HealthHarvard Medical School (HMS and HSDM); National Institute on Drug Abuse (NIDA) and other collaboratorsRecruitingOpioid Use Disorder (OUD)United States
-
Friends Research Institute, Inc.RecruitingOpioid-use DisorderUnited States
-
University of OxfordRecruitingPsoriatic ArthritisUnited Kingdom
-
The University of Hong KongNorth District Hospital; Queen Mary Hospital, Hong KongRecruitingSchizophrenia and Related Disorders | Stimulant Dependence | Pharmacotherapy | Stimulant Use With Stimulant-Induced Psychotic Disorder (Diagnosis) | Stimulant AbuseHong Kong
-
Janssen-Cilag International NVCompleted
-
Sage TherapeuticsCompletedEssential TremorUnited States
-
Luye Pharma Group Ltd.CompletedMental Disorders | Psychotic Disorders | Mood Disorders | Schizophrenia | Schizophrenia Spectrum and Other Psychotic Disorders | Molecular Mechanisms of Pharmacological Action | Tranquilizing Agents | Physiological Effects of Drugs | Psychotropic Drugs | Antipsychotic Agents | Neurotransmitter Agents | Central...United States
-
University of New MexicoPatient-Centered Outcomes Research Institute; Montana State University; National... and other collaboratorsTerminated
-
Vir Biotechnology, Inc.GlaxoSmithKlineTerminatedCovid19United States, France, Ukraine
-
Janssen Research & Development, LLCCompleted
-
Hangzhou Highlightll Pharmaceutical Co., LtdCompleted
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)SuspendedExtended-Release Buprenorphine vs. Sublingual Buprenorphine for the Treatment of Opioid Use DisorderOpioid-use DisorderUnited States
-
Janssen Research & Development, LLCCompletedSchizophreniaUnited States, Korea, Republic of, Hong Kong, Taiwan, Malaysia, Czechia, Poland, Brazil, India, Spain, Argentina, Bulgaria, Turkey, Russian Federation, Ukraine, Hungary, South Africa, Mexico, Australia, France, Italy
-
Erin McCrearyUniversity of PittsburghTerminated
-
Janssen Research & Development, LLCCompletedSchizophreniaHong Kong, Poland, Argentina, Russian Federation, Ukraine, Italy
-
Titan PharmaceuticalsTerminatedParkinson DiseaseUnited States
-
Luye Pharma Group Ltd.CompletedMental Disorders | Psychotic Disorders | Mood Disorders | Schizophrenia | Molecular Mechanisms of Pharmacological Action | Tranquilizing Agents | Physiological Effects of Drugs | Psychotropic Drugs | Antipsychotic Agents | Central Nervous System Depressants | Neurotransmitter Agents | Schizophrenia SpectrumUnited States
-
Corcept TherapeuticsCompletedAntipsychotic-induced Weight Gain (AIWG)United States
-
Lyndra Inc.National Institute on Drug Abuse (NIDA)WithdrawnOpioid Use Disorder, Moderate
-
Astellas Pharma Global Development, Inc.Completed
-
University of California, Los AngelesNational Institute of Mental Health (NIMH); Janssen Scientific Affairs, LLCCompletedSchizophrenia (Recent-onset)United States
-
Epirium Bio Inc.CompletedBecker Muscular DystrophyUnited States
-
University of Maryland, BaltimoreWithdrawnSchizophreniaUnited States
-
Organon and CoCompleted
-
NYU Langone HealthNYC Health + HospitalsCompleted
-
Janssen Scientific Affairs, LLCCompletedPsychotic Disorders | SchizophreniaUnited States, Brazil, Mexico
-
University of California, San DiegoAmerican Heart AssociationCompletedStatin IntoleranceUnited States
-
Juntendo UniversityCompleted
-
Yale UniversityUniversity of South Florida; New York University; Icahn School of Medicine at... and other collaboratorsCompleted
-
Janssen-Cilag Farmaceutica Ltda.Completed
-
ShireCompletedAttention-Deficit/Hyperactivity DisorderUnited States, Canada
-
Janssen-Cilag International NVCompletedSchizophreniaFrance, United Kingdom, Belgium, Germany, Spain, Portugal, Bulgaria, Serbia, Switzerland, Israel, Finland, Greece, Sweden, Russian Federation, Netherlands, Denmark, Hungary, Lithuania, Latvia, Croatia, Turkey, Poland
-
Calo Psychiatric CenterCompleted
-
Janssen Korea, Ltd., KoreaCompletedSchizophreniaKorea, Republic of
-
Luye Pharma Group Ltd.Alliance for Clinical Trials in Oncology; Evolution Research GroupCompletedSchizophrenia PatientsUnited States
-
UMC UtrechtCompletedSchizophreniaNetherlands, Norway, Austria, Belgium, Bulgaria, Czechia, Denmark, Germany, Greece, Hungary, Israel, Italy, Poland, Romania, Spain, United Kingdom
-
NYU Langone HealthNational Institute on Drug Abuse (NIDA); The Emmes Company, LLCCompletedOpioid Use DisorderUnited States
-
Alkermes, Inc.CompletedSchizophreniaUnited States
-
Yale UniversityNational Institute of Mental Health (NIMH); Massachusetts General Hospital; University... and other collaboratorsCompletedPervasive Development DisordersUnited States